Livestock Vaccines Market (Vaccine Type: Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others; and Technology: Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends,

Livestock Vaccines Market (Vaccine Type: Bovine Vaccine, Poultry Vaccine, Porcine Vaccine, and Others; and Technology: Live Attenuated Vaccine, Inactivated Vaccine, Recombinant Vaccine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Livestock Vaccines Market – Scope of Report

TMR’s report on the global livestock vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global livestock vaccines market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global livestock vaccines market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the livestock vaccines market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global livestock vaccines market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global livestock vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global livestock vaccines market.

The report delves into the competitive landscape of the global livestock vaccines market. Key players operating in the global livestock vaccines market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global livestock vaccines market profiled in this report.

Key Questions Answered in Global livestock vaccines Market Report
  • What is the sales/revenue generated by livestock vaccines across all regions during the forecast period?
  • What are the opportunities in the global livestock vaccines market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Livestock Vaccines Market – Research Objectives and Research Approach

The comprehensive report on the global livestock vaccines market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global livestock vaccines market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global livestock vaccines market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Livestock Vaccines Market
4. Market Overview
4.1. Introduction
  4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. Global Livestock Vaccines Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Disease Epidemiology
5.2. Pipeline Analysis
5.3. Key Industry Events
5.4. COVID-19 Pandemic Impact on Industry
6. Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Vaccine Type, 2023–2031
  6.3.1. Bovine Vaccine
  6.3.2. Poultry Vaccine
  6.3.3. Porcine Vaccine
  6.3.4. Others
6.4. Market Attractiveness Analysis, by Vaccine Type
7. Global Livestock Vaccines Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2023–2031
  7.3.1. Live Attenuated Vaccine
  7.3.2. Inactivated Vaccine
  7.3.3. Recombinant Vaccine
  7.3.4. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Route of Administration, 2023–2031
  8.3.1. Oral
  8.3.2. Parenteral
  8.3.3. Others
8.4. Market Attractiveness Analysis, by Route of Administration
9. Global Livestock Vaccines Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2023–2031
  9.3.1. Veterinary Hospitals
  9.3.2. Veterinary Clinics
  9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Livestock Vaccines Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2023–2031
  10.2.1. North America
  10.2.2. Europe
  10.2.3. Asia Pacific
  10.2.4. Latin America
  10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Livestock Vaccines Market Analysis and Forecast
11.1. Introduction
  11.1.1. Key Findings
11.2. Market Value Forecast, by Vaccine Type, 2023–2031
  11.2.1. Bovine Vaccine
  11.2.2. Poultry Vaccine
  11.2.3. Poultry Vaccine
  11.2.4. Others
11.3. Market Value Forecast, by Technology, 2023–2031
  11.3.1. Live Attenuated Vaccine
  11.3.2. Inactivated Vaccine
  11.3.3. Recombinant Vaccine
  11.3.4. Others
11.4. Market Value Forecast, by Route of Administration, 2023–2031
  11.4.1. Oral
  11.4.2. Parenteral
  11.4.3. Others
11.5. Market Value Forecast, by End-user, 2023–2031
  11.5.1. Veterinary Hospitals
  11.5.2. Veterinary Clinics
  11.5.3. Others
11.6. Market Value Forecast, by Country, 2023–2031
  11.6.1. U.S.
  11.6.2. Canada
11.7. Market Attractiveness Analysis
  11.7.1. By Vaccine Type
  11.7.2. By Technology
  11.7.3. By Route of Administration
  11.7.4. By End-user
  11.7.5. By Country/Sub-region
12. Europe Livestock Vaccines Market Analysis and Forecast
12.1. Introduction
  12.1.1. Key Findings
12.2. Market Value Forecast, by Vaccine Type, 2023–2031
  12.2.1. Bovine Vaccine
  12.2.2. Poultry Vaccine
  12.2.3. Porcine Vaccine
  12.2.4. Others
12.3. Market Value Forecast, by Technology, 2023–2031
  12.3.1. Live Attenuated Vaccine
  12.3.2. Inactivated Vaccine
  12.3.3. Recombinant Vaccine
  12.3.4. Others
12.4. Market Value Forecast, by Route of Administration, 2023–2031
  12.4.1. Oral
  12.4.2. Parenteral
  12.4.3. Others
12.5. Market Value Forecast, by End-user, 2023–2031
  12.5.1. Veterinary Hospitals
  12.5.2. Veterinary Clinics
  12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2023–2031
  12.6.1. Germany
  12.6.2. U.K.
  12.6.3. France
  12.6.4. Italy
  12.6.5. Spain
  12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
  12.7.1. By Vaccine Type
  12.7.2. By Technology
  12.7.3. By Route of Administration
  12.7.4. By End-user
  12.7.5. By Country/Sub-region
13. Asia Pacific Livestock Vaccines Market Analysis and Forecast
13.1. Introduction
  13.1.1. Key Findings
13.2. Market Value Forecast, by Vaccine Type, 2023–2031
  13.2.1. Bovine Vaccine
  13.2.2. Poultry Vaccine
  13.2.3. Porcine Vaccine
  13.2.4. others
13.3. Market Value Forecast, by Technology, 2023–2031
  13.3.1. Live Attenuated Vaccine
  13.3.2. Inactivated Vaccine
  13.3.3. Recombinant Vaccine
  13.3.4. Others
13.4. Market Value Forecast, by Route of Administration, 2023–2031
  13.4.1. Oral
  13.4.2. Parenteral
  13.4.3. Others
13.5. Market Value Forecast, by End-user, 2023–2031
  13.5.1. Veterinary Hospitals
  13.5.2. Veterinary Clinics
  13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2023–2031
  13.6.1. China
  13.6.2. Japan
  13.6.3. India
  13.6.4. Australia & New Zealand
  13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
  13.7.1. By Vaccine Type
  13.7.2. By Technology
  13.7.3. By Route of Administration
  13.7.4. By End-user
  13.7.5. By Country/Sub-region
14. Latin America Livestock Vaccines Market Analysis and Forecast
14.1. Introduction
  14.1.1. Key Findings
14.2. Market Value Forecast, by Vaccine Type, 2023–2031
  14.2.1. Bovine Vaccine
  14.2.2. Poultry Vaccine
  14.2.3. Porcine Vaccine
  14.2.4. Others Vaccine
14.3. Market Value Forecast, by Technology, 2023–2031
  14.3.1. Live Attenuated Vaccine
  14.3.2. Inactivated Vaccine
  14.3.3. Recombinant Vaccine
  14.3.4. Others
14.4. Market Value Forecast, by Route of Administration, 2023–2031
  14.4.1. Oral
  14.4.2. Parenteral
  14.4.3. Others
14.5. Market Value Forecast, by End-user, 2023–2031
  14.5.1. Veterinary Hospitals
  14.5.2. Veterinary Clinics
  14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2023–2031
  14.6.1. Brazil
  14.6.2. Mexico
  14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
  14.7.1. By Vaccine Type
  14.7.2. By Technology
  14.7.3. By Route of Administration
  14.7.4. By End-user
  14.7.5. By Country/Sub-region
15. Middle East & Africa Livestock Vaccines Market Analysis and Forecast
15.1. Introduction
  15.1.1. Key Findings
15.2. Market Value Forecast, by Vaccine Type, 2023–2031
  15.2.1. Bovine Vaccine
  15.2.2. Poultry Vaccine
  15.2.3. Porcine Vaccine
  15.2.4. Others
15.3. Market Value Forecast, by Technology, 2023–2031
  15.3.1. Live Attenuated Vaccine
  15.3.2. Inactivated Vaccine
  15.3.3. Recombinant Vaccine
  15.3.4. Others
15.4. Market Value Forecast, by Route of Administration, 2023–2031
  15.4.1. Oral
  15.4.2. Parenteral
  15.4.3. Others
15.5. Market Value Forecast, by End-user, 2023–2031
  15.5.1. Veterinary Hospitals
  15.5.2. Veterinary Clinics
  15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2023–2031
  15.6.1. GCC Countries
  15.6.2. South Africa
  15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
  15.7.1. By Vaccine Type
  15.7.2. By Technology
  15.7.3. By Route of Administration
  15.7.4. By End-user
  15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
  16.3.1. Dechra Pharmaceuticals PLC
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
  16.3.2. Ceva Santé Animale
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
  16.3.3. Elanco
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
  16.3.4. Merck & Co., Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
  16.3.5. Zoetis Services LLC
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
  16.3.6. Boehringer Ingelheim International GmbH.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
  16.3.7. Virbac
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
  16.3.8. Biogénesis Bagó
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
  16.3.9. Ourofino Saúde Animal
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
  16.3.10. VETAL Animal Health Products, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
  16.3.11. Other prominent Players
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings